organization · Reporting owner

ISP V-B EF LP

Disclosed activity across 1 company

Tapewire entity: 80593
SEC CIK: 0001889306

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Enfusion, Inc.

Report date April 21, 2025 · Filed April 23, 2025

Jointly reported with ICONIQ Strategic Partners V, L.P., ICONIQ Strategic Partners V-B, L.P., ISP V Main Fund EF LLC, ICONIQ STRATEGIC PARTNERS V GP, L.P., ICONIQ Strategic Partners V TT GP, Ltd., Makan Divesh, Griffith William J.G., Jacobson Matthew

Section 16 reporting ended · disclosed 2025-04-23. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	Reported balance After 2025-04-21 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2025-04-21 · Other · Disposed 538,887 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion. F2: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); F3: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F4: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share. F5: The shares are held by ICONIQ Strategic Partners V, L.P. ("ICONIQ V"). F6: ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ V, ICONIQ Strategic Partners V-B, L.P. ("ICONIQ V-B") and ISP V-B EF LP ("ISP V-B EF"). ICONIQ V is the sole managing member of ISP V Main Fund EF LLC ("ISP V EF"). ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP. Divesh Makan ("Makan"), William J.G. Griffith ("Griffith") and Matthew Jacobson ("Jacobson") are the sole equity holders of ICONIQ V Parent GP. F7: Each of ICONIQ V, ICONIQ V GP, ICONIQ V Parent GP, Makan, Griffith and Jacobson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Class A Common StockSEC Table I · non-derivative	IndirectBy ICONIQ Strategic Partners V-B, L.P.	Reported balance After 2025-04-21 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2025-04-21 · Other · Disposed 722,707 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion. F2: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); F3: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F4: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share. F6: ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ V, ICONIQ Strategic Partners V-B, L.P. ("ICONIQ V-B") and ISP V-B EF LP ("ISP V-B EF"). ICONIQ V is the sole managing member of ISP V Main Fund EF LLC ("ISP V EF"). ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP. Divesh Makan ("Makan"), William J.G. Griffith ("Griffith") and Matthew Jacobson ("Jacobson") are the sole equity holders of ICONIQ V Parent GP. F7: Each of ICONIQ V, ICONIQ V GP, ICONIQ V Parent GP, Makan, Griffith and Jacobson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. F8: The shares are held by ICONIQ V-B.
Class A Common StockSEC Table I · non-derivative	IndirectBy ISP V-B EF LP	Reported balance After 2025-04-21 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2025-04-21 · Other · Disposed 7,748,000 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion. F2: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); F3: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F4: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share. F6: ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ V, ICONIQ Strategic Partners V-B, L.P. ("ICONIQ V-B") and ISP V-B EF LP ("ISP V-B EF"). ICONIQ V is the sole managing member of ISP V Main Fund EF LLC ("ISP V EF"). ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP. Divesh Makan ("Makan"), William J.G. Griffith ("Griffith") and Matthew Jacobson ("Jacobson") are the sole equity holders of ICONIQ V Parent GP. F7: Each of ICONIQ V, ICONIQ V GP, ICONIQ V Parent GP, Makan, Griffith and Jacobson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. F9: The shares are held by ISP V-B EF.
Common Units of Enfusion Ltd. LLCSEC Table II · derivative / convertible security	IndirectBy ISP V Main Fund EF LLC	Reported balance After 2025-04-21 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2025-04-21 · Other · Disposed 5,030,000 · Balance 0 F10: Common Units of Enfusion Ltd. LLC (the "Common Units") were exchangeable for shares of the Issuer's Class A common stock on a one-for-one basis and had no expiration date. Each Common Unit was represented by one share of Enfusion's Class B common stock, par value $0.001 per share (the "Class B Common Stock"), which had no economic value and entitled holders thereof to one vote per share on all matters on which stockholders of the Issuer are entitled to vote generally. Upon the automatic exchange of Common Units described in footnote (2) above, each corresponding share of Class B Common Stock was cancelled for no consideration. F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion. F2: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); F3: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F4: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share. F6: ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ V, ICONIQ Strategic Partners V-B, L.P. ("ICONIQ V-B") and ISP V-B EF LP ("ISP V-B EF"). ICONIQ V is the sole managing member of ISP V Main Fund EF LLC ("ISP V EF"). ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP. Divesh Makan ("Makan"), William J.G. Griffith ("Griffith") and Matthew Jacobson ("Jacobson") are the sole equity holders of ICONIQ V Parent GP. F7: Each of ICONIQ V, ICONIQ V GP, ICONIQ V Parent GP, Makan, Griffith and Jacobson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. F11: The shares are held by ISP V EF.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion.

F2: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration");

F3: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration").

F4: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share.

F5: The shares are held by ICONIQ Strategic Partners V, L.P. ("ICONIQ V").

F6: ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ V, ICONIQ Strategic Partners V-B, L.P. ("ICONIQ V-B") and ISP V-B EF LP ("ISP V-B EF"). ICONIQ V is the sole managing member of ISP V Main Fund EF LLC ("ISP V EF"). ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP. Divesh Makan ("Makan"), William J.G. Griffith ("Griffith") and Matthew Jacobson ("Jacobson") are the sole equity holders of ICONIQ V Parent GP.

F7: Each of ICONIQ V, ICONIQ V GP, ICONIQ V Parent GP, Makan, Griffith and Jacobson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

F8: The shares are held by ICONIQ V-B.

F9: The shares are held by ISP V-B EF.

F10: Common Units of Enfusion Ltd. LLC (the "Common Units") were exchangeable for shares of the Issuer's Class A common stock on a one-for-one basis and had no expiration date. Each Common Unit was represented by one share of Enfusion's Class B common stock, par value $0.001 per share (the "Class B Common Stock"), which had no economic value and entitled holders thereof to one vote per share on all matters on which stockholders of the Issuer are entitled to vote generally. Upon the automatic exchange of Common Units described in footnote (2) above, each corresponding share of Class B Common Stock was cancelled for no consideration.

F11: The shares are held by ISP V EF.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
April 21, 2025 Filed Apr 23, 2025 16:30 UTC	Enfusion, Inc. ENFN · Entity 80590	OtherCommon Units of Enfusion Ltd. LLC · Derivative	5,030,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-057455 · ownership.xml · derivative · entry 4 ICONIQ Strategic Partners V, L.P. · CIK 0001816067 · 10% owner ICONIQ Strategic Partners V-B, L.P. · CIK 0001816068 · 10% owner ISP V Main Fund EF LLC · CIK 0001885786 · 10% owner ISP V-B EF LP · CIK 0001889306 · 10% owner ICONIQ Strategic Partners V GP, L.P. · CIK 0001825883 · 10% owner ICONIQ Strategic Partners V TT GP, Ltd. · CIK 0001825921 · 10% owner Makan Divesh · CIK 0001688143 · 10% owner Griffith William J.G. · CIK 0001688124 · 10% owner Jacobson Matthew · CIK 0001783518 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By ISP V Main Fund EF LLC Disclosed balance after: 0 Underlying: Class A Common Stock · 5,030,000 shares Expires not disclosed F10 · derivative.exercise_price: Common Units of Enfusion Ltd. LLC (the "Common Units") were exchangeable for shares of the Issuer's Class A common stock on a one-for-one basis and had no expiration date. Each Common Unit was represented by one share of Enfusion's Class B common stock, par value $0.001 per share (the "Class B Common Stock"), which had no economic value and entitled holders thereof to one vote per share on all matters on which stockholders of the Issuer are entitled to vote generally. Upon the automatic exchange of Common Units described in footnote (2) above, each corresponding share of Class B Common Stock was cancelled for no consideration. F1 · kind: Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion. F2 · kind: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); F3 · kind: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F4 · shares: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share. F2 · price: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); F3 · price: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F4 · price: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share. F10 · derivative.exercise_date: Common Units of Enfusion Ltd. LLC (the "Common Units") were exchangeable for shares of the Issuer's Class A common stock on a one-for-one basis and had no expiration date. Each Common Unit was represented by one share of Enfusion's Class B common stock, par value $0.001 per share (the "Class B Common Stock"), which had no economic value and entitled holders thereof to one vote per share on all matters on which stockholders of the Issuer are entitled to vote generally. Upon the automatic exchange of Common Units described in footnote (2) above, each corresponding share of Class B Common Stock was cancelled for no consideration. F10 · derivative.expiration_date: Common Units of Enfusion Ltd. LLC (the "Common Units") were exchangeable for shares of the Issuer's Class A common stock on a one-for-one basis and had no expiration date. Each Common Unit was represented by one share of Enfusion's Class B common stock, par value $0.001 per share (the "Class B Common Stock"), which had no economic value and entitled holders thereof to one vote per share on all matters on which stockholders of the Issuer are entitled to vote generally. Upon the automatic exchange of Common Units described in footnote (2) above, each corresponding share of Class B Common Stock was cancelled for no consideration. F6 · ownership.direct: ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ V, ICONIQ Strategic Partners V-B, L.P. ("ICONIQ V-B") and ISP V-B EF LP ("ISP V-B EF"). ICONIQ V is the sole managing member of ISP V Main Fund EF LLC ("ISP V EF"). ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP. Divesh Makan ("Makan"), William J.G. Griffith ("Griffith") and Matthew Jacobson ("Jacobson") are the sole equity holders of ICONIQ V Parent GP. F7 · ownership.direct: Each of ICONIQ V, ICONIQ V GP, ICONIQ V Parent GP, Makan, Griffith and Jacobson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. F11 · ownership.direct: The shares are held by ISP V EF. Read SEC document
April 21, 2025 Filed Apr 23, 2025 16:30 UTC	Enfusion, Inc. ENFN · Entity 80590	OtherClass A Common Stock	7,748,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-057455 · ownership.xml · nonDerivative · entry 3 ICONIQ Strategic Partners V, L.P. · CIK 0001816067 · 10% owner ICONIQ Strategic Partners V-B, L.P. · CIK 0001816068 · 10% owner ISP V Main Fund EF LLC · CIK 0001885786 · 10% owner ISP V-B EF LP · CIK 0001889306 · 10% owner ICONIQ Strategic Partners V GP, L.P. · CIK 0001825883 · 10% owner ICONIQ Strategic Partners V TT GP, Ltd. · CIK 0001825921 · 10% owner Makan Divesh · CIK 0001688143 · 10% owner Griffith William J.G. · CIK 0001688124 · 10% owner Jacobson Matthew · CIK 0001783518 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By ISP V-B EF LP Disclosed balance after: 0 F1 · kind: Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion. F2 · kind: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); F3 · kind: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F4 · shares: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share. F2 · price: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); F3 · price: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F4 · price: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share. F6 · ownership.direct: ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ V, ICONIQ Strategic Partners V-B, L.P. ("ICONIQ V-B") and ISP V-B EF LP ("ISP V-B EF"). ICONIQ V is the sole managing member of ISP V Main Fund EF LLC ("ISP V EF"). ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP. Divesh Makan ("Makan"), William J.G. Griffith ("Griffith") and Matthew Jacobson ("Jacobson") are the sole equity holders of ICONIQ V Parent GP. F7 · ownership.direct: Each of ICONIQ V, ICONIQ V GP, ICONIQ V Parent GP, Makan, Griffith and Jacobson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. F9 · ownership.direct: The shares are held by ISP V-B EF. Read SEC document
April 21, 2025 Filed Apr 23, 2025 16:30 UTC	Enfusion, Inc. ENFN · Entity 80590	OtherClass A Common Stock	722,707	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-057455 · ownership.xml · nonDerivative · entry 2 ICONIQ Strategic Partners V, L.P. · CIK 0001816067 · 10% owner ICONIQ Strategic Partners V-B, L.P. · CIK 0001816068 · 10% owner ISP V Main Fund EF LLC · CIK 0001885786 · 10% owner ISP V-B EF LP · CIK 0001889306 · 10% owner ICONIQ Strategic Partners V GP, L.P. · CIK 0001825883 · 10% owner ICONIQ Strategic Partners V TT GP, Ltd. · CIK 0001825921 · 10% owner Makan Divesh · CIK 0001688143 · 10% owner Griffith William J.G. · CIK 0001688124 · 10% owner Jacobson Matthew · CIK 0001783518 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By ICONIQ Strategic Partners V-B, L.P. Disclosed balance after: 0 F1 · kind: Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion. F2 · kind: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); F3 · kind: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F4 · shares: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share. F2 · price: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); F3 · price: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F4 · price: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share. F6 · ownership.direct: ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ V, ICONIQ Strategic Partners V-B, L.P. ("ICONIQ V-B") and ISP V-B EF LP ("ISP V-B EF"). ICONIQ V is the sole managing member of ISP V Main Fund EF LLC ("ISP V EF"). ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP. Divesh Makan ("Makan"), William J.G. Griffith ("Griffith") and Matthew Jacobson ("Jacobson") are the sole equity holders of ICONIQ V Parent GP. F7 · ownership.direct: Each of ICONIQ V, ICONIQ V GP, ICONIQ V Parent GP, Makan, Griffith and Jacobson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. F8 · ownership.direct: The shares are held by ICONIQ V-B. Read SEC document
April 21, 2025 Filed Apr 23, 2025 16:30 UTC	Enfusion, Inc. ENFN · Entity 80590	OtherClass A Common Stock	538,887	Not disclosed	Not disclosed	Disclosure SEC source: 0000950170-25-057455 · ownership.xml · nonDerivative · entry 1 ICONIQ Strategic Partners V, L.P. · CIK 0001816067 · 10% owner ICONIQ Strategic Partners V-B, L.P. · CIK 0001816068 · 10% owner ISP V Main Fund EF LLC · CIK 0001885786 · 10% owner ISP V-B EF LP · CIK 0001889306 · 10% owner ICONIQ Strategic Partners V GP, L.P. · CIK 0001825883 · 10% owner ICONIQ Strategic Partners V TT GP, Ltd. · CIK 0001825921 · 10% owner Makan Divesh · CIK 0001688143 · 10% owner Griffith William J.G. · CIK 0001688124 · 10% owner Jacobson Matthew · CIK 0001783518 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed of pursuant to the Agreement and Plan of Merger, dated as of January 10, 2025 (the "Merger Agreement"), by and among Clearwater Analytics Holdings, Inc. (the "Parent"), Poseidon Acquirer, Inc., a direct, wholly-owned subsidiary of the Parent, Poseidon Merger Sub I, Inc., a wholly-owned subsidiary of the Parent, Poseidon Merger Sub II, LLC, an indirect subsidiary of the Parent, Enfusion, Inc. ("Enfusion"), and Enfusion Ltd. LLC, a subsidiary of Enfusion. F2 · kind: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); F3 · kind: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F4 · shares: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share. F2 · price: Under the terms of the Merger Agreement, each eligible share of Enfusion's Class A common stock, par value $0.001 per share (the "Common Stock") and each Common Unit of Enfusion Ltd. LLC (the "Common Units" and together with the shares of Common Stock, the "Eligible Shares"), issued and outstanding was converted into the right to receive, at the election of the holder of such Eligible Share, and subject to proration in accordance with the Merger Agreement: (i) cash in an amount equal to $5.85 and (ii) a number of shares of Class A common stock of the Parent, par value $0.001 per share (the "Parent Common Stock") equal to the Per Share Parent Stock Amount (as defined in the Merger Agreement) (the "Per Share Mixed Consideration"); (ii) a number of shares of Parent Common Stock equal to the Exchange Ratio (the "Per Share Stock Consideration"); F3 · price: (Continued from footnote 2) or (iii) cash in an amount equal to the Aggregate Consideration Per Share (as defined in the Merger Agreement) (the "Per Share Cash Consideration"). F4 · price: Represents Eligible Shares, which were converted into the right to receive the merger consideration, at the election of the holder of such Eligible Share. F5 · ownership.direct: The shares are held by ICONIQ Strategic Partners V, L.P. ("ICONIQ V"). F6 · ownership.direct: ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ V, ICONIQ Strategic Partners V-B, L.P. ("ICONIQ V-B") and ISP V-B EF LP ("ISP V-B EF"). ICONIQ V is the sole managing member of ISP V Main Fund EF LLC ("ISP V EF"). ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP. Divesh Makan ("Makan"), William J.G. Griffith ("Griffith") and Matthew Jacobson ("Jacobson") are the sole equity holders of ICONIQ V Parent GP. F7 · ownership.direct: Each of ICONIQ V, ICONIQ V GP, ICONIQ V Parent GP, Makan, Griffith and Jacobson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.